Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

5

Revenue 2017

Merck & Co.

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck & Co.'s 2013 sales performance.

Merck

Novavax to provide 1.1 billon COVID-19 vaccine doses to COVAX

Novavax to provide 1.1 billon COVID-19 vaccine doses to COVAX COVAX is the vaccine pillar of the WHO’s ACT Accelerator – a collaborative initiative co-led by Gavi, the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI)

AZ/Merck & Co’s PARP inhibitor Lynparza scores trial win in early breast cancer

AZ/Merck & Co’s PARP inhibitor Lynparza scores trial win in early breast cancer AstraZeneca and Merck &Co (MSD) have revealed positive results for their PARP inhibitor Lynparza in the early, adjuvant setting for certain breast cancer patients. ... said Roy Baynes, senior vice president and head of global clinical development, chief

Lilly signs $960m deal with Rigel to develop RIPK1 inhibitors

Lilly signs $960m deal with Rigel to develop RIPK1 inhibitors Companies will co-develop molecules for the treatment of immunological and neurodegenerative diseases. ... Lilly will co-develop and commercialise R552 across all indications, including autoimmune and inflammatory diseases.

Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU

Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU We have taken additional steps to expand our manufacturing capacity to two billion doses in 2021,” said Ugur Sahin, chief executive officer and co-founder of BioNTech.

South African variant reduces antibody levels produced by Pifzer/BioNTech’s COVID-19 vaccine

South African variant reduces antibody levels produced by Pifzer/BioNTech’s COVID-19 vaccine Pei-Yong Shim, professor at UTMB and co-author of the study, told Reuters that he believes the Pfizer/BioNTech vaccine is still ‘likely’ to offer protection against the SA variant.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics